CLINICAL_TRIALS ClinicalTrials.gov record update

STM-02: Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing Insulin-like Growth Factor Receptor 1 (IGF-1R)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02045368
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:11.291172+00:00
Published At: 2019-08-22T00:00:00+00:00
Record Updated At: 2019-08-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "Brain Cancer", "Gastrointestinal Cancers", "Genitourinary Cancers", "Gynecologic Cancers", "Head and Neck Cancers", "Melanoma", "Thoracic Cancers"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-08-22"
protocolSection.identificationModule.nctId: "NCT02045368"
protocolSection.identificationModule.officialTitle: "STM-02: Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing Insulin-like Growth Factor Receptor 1 (IGF-1R)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.